x

Join Advarra

Learn more about our company team, careers, and values. Join Advarra’s Talented team to take on engaging work in a dynamic environment.

See Jobs

 
Blog

The Challenge of Unproven Regenerative Stem Cell Therapies

Stem cell clinics with unproven treatments are on the rise in the US. Learn how the FDA is working to bring new stem cell therapies under federal oversight.

Read Now
7 min. read
Read more
 
Blog

Survey Best Practices for Process Improvement

Learn best practices of survey creation to help measure process improvement among stakeholders at an organization.

Read Now
5 min. read
Read more
 
Blog

Six Key GDPR Questions to Review

Questions still remain about GDPR and its applications. Have you considered these six key questions to ask within your organization?

Read Now
5 min. read
Read more
 
Blog

Can Ethics Review Catch Up to the CBD Craze?

CBD, a non-psychoactive cannabinoid, is experiencing a massive surge in popularity, but clinical research lags behind in verifying effective uses.

Read Now
4 min. read
Read more
 
Blog

Quorum/Kinetiq Acquisition & Integration:
What You Need to Know

On March 5, 2019, Advarra announced its acquisition of Quorum Review IRB and Kinetiq, the research and technology consulting division of Quorum.

Read Now
Read more
 
Blog

After the Compliance Date: Revised Common Rule FAQs (Or: Why We Cancelled Our February Webinar)

We have cancelled our webinar “After the Compliance Date: Revised Common Rule FAQs,” which was originally scheduled for February 28.

Read Now
Read more
 
Blog

Informed Consent Changes in the Revised Common Rule

If your research must comply with the revised Common Rule, you’ll need to update the way you write ICFs to meet the new requirements.

Read Now
4 min. read
Read more
 
Blog

Do I Need to Comply With the Revised Common Rule?

While many US researchers are aware of the coming Common Rule changes, not everyone is sure whether they will need to comply with the revised regulations.

Read Now
4 min. read
Read more
 
Blog

Infection Control and Biosafety in Gene Therapy Research

Given the growth in gene therapy research, sponsors, CROs and sites have become increasingly curious about the requirements to be able to conduct such studies.

Read Now
4 min. read
Read more
 
Blog

Integration Update: Leading Compliance Adherence

The Advarra team is proud to announce that all major integration activities are now complete.

Read Now
3 min. read
Read more
 
Blog

ICH-GCP Guidelines and Research Conducted in the US

Learn the basics of how ICH-GCP Guidelines can impact the study ICF and how we at Advarra came to our updated policy on the topic.

Read Now
3 min. read
Read more
 
Blog

What’s the Difference Between Right to Try and Expanded Access?

Let’s take a look at the basics of what each program does and does not do for patients seeking to access investigational therapies.

Read Now
5 min. read
Read more